AME Medical JournalAME医学杂志

AME Medical Journal(英文缩写 AME MED J),ISSN 2520-0518,eISSN 2520-0518,中文译名:AME医学杂志 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。

2026 年数据 · 影响因子
0.800
JCR 分区
Q3
CAS 分区
-
近一年发文量
0
本站 PubMed 收录统计

发文量统计区间:2025-10-01 至 2026-09-30,按本站收录文献的发表日期统计。

ISSN: 2520-0518 · eISSN: 2520-0518 · 缩写: AME MED J ·中文: AME医学杂志

期刊介绍

选择期刊介绍栏目

期刊简介

AME Medical Journal 是一本面向临床与转化医学的开放获取期刊,关注内科、外科及交叉学科中的实践问题与循证进展。内容涵盖疾病诊断、治疗策略、预后评估及医疗技术应用,读者主要为临床医师、医学研究人员和研究生。期刊强调研究对临床决策的参考价值,鼓励多中心协作与真实世界数据研究,为不同地区医疗实践提供交流平台。

研究方向

主要方向包括内科各亚专科、外科技术、肿瘤学、心血管与呼吸疾病、影像与检验医学,以及医疗质量与患者管理。论文类型以原创研究、系统综述、荟萃分析和病例报告为主,也接受评论、通讯及方法学探讨,尤其欢迎结合临床数据与转化发现的研究。

期刊特色

研究取向偏重临床实用性与证据整合,论文通常要求明确的研究问题、规范的方法描述和可解释的结果。综述类文章注重批判性归纳而非简单罗列。适合有一定临床数据积累、希望快速发表并参与国际学术对话的医师和科研人员,也适合研究生作为学习写作与投稿的参考。

投稿难度

投稿难度中等,对研究设计的完整性和数据质量有一定要求,但整体门槛低于顶级专科期刊。建议投稿前明确研究创新点,完善统计分析与伦理说明,并针对临床意义充分讨论。若被拒稿,可根据审稿意见补充数据或调整论文类型后改投。

AME Medical Journal 最新收录文献

  1. JCR分区: Q3 CAS分区: N/A 影响因子: 0.8

    1. Disseminated intravascular coagulation after cryoablation for metastatic pancreatic cancer: a case report.

    作者:
    Alina Dulu, Yekaterina Tayban, Joanne Delaleu, Francois H Cornelis, Stephen M Pastores
    日期:
    2023-06-06

    Pancreatic cancer is the fourth most common cause of cancer-related death in the United States. Despite advancements in surgery and chemoradiation therapies, pancreatic cancer has a 5-year survival rate of only 11% in the United States. Cryoablation is emerging as a new and effective therapy for locally advanced pancreatic cancer and symptom palliation in metastatic disease. To our knowledge, the occurrence of disseminated intravascular coagulation (DIC) after cryoablation is rare. A 47-year-old woman with no significant past medical history was diagnosed with pancreatic cancer and underwent a Whipple procedure followed by chemotherapy with gemcitabine and paclitaxel. Due to the abdominal lymph nodes, peritoneum, right femur, and surrounding soft tissue metastases, she received systemic palliative chemotherapy with gemcitabine and paclitaxel and underwent right femur tumor excision, open reduction, and internal fixation, followed by radiation therapy. She continued to have persistent pain and underwent palliative percutaneous cryoablation of the metastatic tumor under computed tomography (CT) and ultrasound guidance. Immediately post procedure, she developed slow but continuous blood oozing at the ablation site, which was difficult to control despite compression dressings, reinforcement sutures, and local thrombin powder. The patient was transferred to the intensive care unit where she was noted to be hypotensive and tachycardic, with petechiae in both lower extremities. Laboratory studies were consistent with DIC and peripheral blood smear revealed multiple schistocytes. CT angiogram of the right lower extremity did not show any bleeding vessel amenable to embolization. She was transfused red blood cells, platelets, fresh frozen plasma, and cryoprecipitate. Despite multiple daily transfusions, she continued to have pain and remained persistently thrombocytopenic and coagulopathic. After discussion with the patient and her family, she chose to transition to comfort care measures and died. DIC is an unusual but life-threatening complication of advanced pancreatic cancer.

  2. JCR分区: Q3 CAS分区: N/A 影响因子: 0.8

    2. A narrative review of genetic biomarkers in non-small cell lung cancer: an update and future perspectives.

    作者:
    Samuel Workman, Salma K Jabbour, Matthew P Deek
    日期:
    2023-02-02

    Lung cancer has long been the leading cause of cancer deaths in the United States. Lung cancer has a poor prognosis, and our understanding of who will maximally benefit from different therapies is incomplete. This article discusses genetic biomarkers that may help in this regard. From origin until February 25, 2022, PubMed database was searched for terms "non-small cell lung cancer", "genomics" and "biomarker", with special attention paid to literature published within the past 10 years. Search was language restricted to English. Additional literature was identified through hand searches of the references of retrieved literature. The most robustly described biomarkers for non-small cell lung cancer (NSCLC) are assessment of specific gene mutations. These are currently used in clinical practice for both prediction and prognostication. Abnormal mutation status of and -NFE2L2 are associated with poor response to radiotherapy (RT), and STK11/LKB1 is further associated with resistance to PD-L1 immunotherapy. Abnormal TP53 is associated with decreased benefit from cisplatin in squamous cell carcinoma (SCC). In terms of prognostication, RB1 mutations are associated with decreased overall survival (OS) in NSCLC and KEAP1-NFE2L2 mutations are associated with increased local recurrence (LR).Additional work has focused on gene expression levels, as well as analysis of genetic factors and signaling molecules affecting the tumor microenvironment (TME). High levels of Rad51c and NFE2L2 are associated with resistance to chemotherapy, and high Rad51c levels are further associated with resistance to RT. High nuclear expression of β-catenin has additionally been associated with poor RT response. Further, there is increasing evidence that some long non-coding RNAs (lncRNAs) may play a crucial role in regulation of tumor radiosensitivity. Much of this work has had promising early results but will require further validation before routine clinical use. Finally, there is evidence that quantification of some signaling molecules and microRNAs (miRNAs) may have clinical utility in predicting adverse outcomes in RT. An improved understanding of tumor genetics in NSCLC has led to the development of targeted therapies and improved prognostication. As more work is done in this field, more and more genetic biomarkers will become candidates for clinical use. Much work will be required to validate these findings in the clinical setting.

  3. JCR分区: Q3 CAS分区: N/A 影响因子: 0.8

    3. 3D printing for airway disease.

    作者:
    Abdul Hamid Alraiyes, Sameer K Avasarala, Michael S Machuzak, Thomas R Gildea
    日期:
    2019-02-13

    It has been 30 years since the first commercial three-dimensional (3D) printer was available on market. The technological advancement of 3D printing has far exceeded its implementation in medicine. The application of 3D printing technology has the potential of playing a major role within interventional pulmonology; specifically, in the management of complex airway disease. Tailoring management to the patient-specific anatomical malformation caused by benign or malignant disease is a major challenge faced by interventional pulmonologists. Such cases often require adjunctive therapeutic procedures with thermal therapies followed by dilation and airway stenting to maintain the patency of the airway. Airway-stent size matching is one key to reducing stent-related complications. A major barrier to matching is the expansion of the stent in two dimensions (fixed sizes in length and diameter) within the deformed airway. Additional challenges are created by the subjective oversizing of the stent to reduce the likelihood of migration. Improper sizing adversely affects the stability of the stent. The stent-airway mismatch can be complicated by airway erosion, perforation, or the formation of granulation tissue. Stents can migrate, fracture, obstruct, or become infected. The use of patient-specific 3D printed airway stents may be able to reduce the stent airway mismatch. These stents allow more precise stent-airway sizing and minimizes high-pressure points on distorted airway anatomy. In theory, this should reduce the incidence of the well-known complications of factory manufactured stents. In this article, the authors present the brief history of 3D printed stents, their consideration in select patients, processing steps for development, and future direction.

  4. JCR分区: Q3 CAS分区: N/A 影响因子: 0.8
  5. JCR分区: Q3 CAS分区: N/A 影响因子: 0.8
  6. JCR分区: Q3 CAS分区: N/A 影响因子: 0.8
  7. JCR分区: Q3 CAS分区: N/A 影响因子: 0.8

    7. Management of sciatica: a shared-decision.

    作者:
    Haley N N Moulton, Jon D Lurie
    日期:
    2018-03-26

    该文献暂无摘要。

  8. JCR分区: Q3 CAS分区: N/A 影响因子: 0.8

在 AME Medical Journal 中搜索更多文献

支持中英文检索 · 智能翻译 · 影响因子 · PDF 下载 · AI 文献阅读

指标接近的期刊